| Literature DB >> 1997101 |
E A Lindsay1, M C Berenbaum, R Bonnett, D G Thomas.
Abstract
Subcutaneous and intracranial VMDk tumours were treated with photodynamic therapy (PDT) using a new sensitiser, m-THPP. Subcutaneous tumours were highly sensitive to PDT but intracranial tumours were much more resistant, requiring a 30-fold increase in sensitiser dose to produce equivalent levels of necrosis. Resistance of intracerebral tumours was not due to failure of the sensitiser to enter tumours. Necrosis of intracranial tumours was increased when mice breathed 100% oxygen during PDT while subcutaneous tumour necrosis was unaffected.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1997101 PMCID: PMC1971766 DOI: 10.1038/bjc.1991.57
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640